Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis

oleh: Akira Hanazono, Yui Sanpei, Hinako Shimada, Keita Yasuda, Yoshiko Takahashi, Homare Funasaka, Ryuichiro Sagehashi, Yuko Hiroshima, Hiroshi Nanjo, Masashiro Sugawara

Format: Article
Diterbitkan: Elsevier 2022-12-01

Deskripsi

Subjek

Interferon β1b; Dimethyl fumarate; Rituximab; IgG4-related disease